Gary Giampetruzzi Appointed to Law360’s 2022 Life Sciences Editorial Board
New York - Paul Hastings LLP, a leading global law firm, announced today that Global Chair of the Life Sciences and Healthcare Vice-Chair of the Investigations and White Collar Defense practices, Gary Giampetruzzi, has been appointed to Law360’s 2022 Life Sciences Editorial Advisory Board, which provides feedback on Law360’s coverage and expert insight on how best to shape future coverage.
The entire Life Sciences Advisory Board can be found here (subscription required). Coverage notes Giampetruzzi’s in-house career as “the longtime deputy compliance officer and head of government investigations at Pfizer Inc. and his role at Paul Hastings. Giampetruzzi is a frequent collaborator with Law360 and is among the most recognized thought leaders and practitioners in the life sciences sector over the past 20-plus years.”
In addition to his firm leadership role, Giampetruzzi routinely advises clients on day-to-day compliance matters, represents corporations in high-profile federal and state investigations, including those involving federal and state False Claims Act (qui tam suits) and the Foreign Corrupt Practices Act. Mr. Giampetruzzi possesses deep experience in the life sciences sector, representing many of the world’s most prominent biotech, pharmaceutical, and medical device companies.
Dedicated to helping clients navigate their most challenging legal issues, significant and complex transactions and most critical disputes, Paul Hastings is a premier global law firm with elite teams in every practice area, jurisdiction and key geography.
Our unmatched client service has helped us become one of the legal profession’s most admired firms, known for a diverse and highly collaborative culture that delivers innovative solutions.